Top 5 Medical Stocks For 2019

By Emily Gurnon, Next Avenue Contributor 

When Sol Moran, 63, left her home in Puerto Rico to move to Minneapolis, things initially went well. She enjoyed being closer to her son, who lived in a nearby suburb, and she had a job she enjoyed. Then Moran got hit with a constellation of serious illnesses. She wasn’t able to keep up her work as an interpreter and home health aide and didn’t have the energy to get out of her apartment for anything other than medical visits.

Her world became very small.

“I had given up on life,” Moran said last week. “I was wondering sometimes why I had a phone,” since the only calls she received were about doctors’ appointments.

Credit: Shutterstock

‘A Potent Killer’

Loneliness and social isolation are not merely a source of sadness for many older adults. Studies have shown that isolation increases the risk of mental and physical illnesses. In fact, the health risks of prolonged isolation are equivalent to smoking 15 cigarettes a day, according to the AARP Foundation.

Top 5 Medical Stocks For 2019: FormFactor, Inc.(FORM)

Advisors’ Opinion:

  • [By Max Byerly]

    FormFactor, Inc. (NASDAQ:FORM) – Equities researchers at B. Riley dropped their FY2018 earnings per share (EPS) estimates for FormFactor in a research report issued to clients and investors on Monday, July 30th. B. Riley analyst C. Ellis now anticipates that the semiconductor company will post earnings of $0.74 per share for the year, down from their prior forecast of $0.98. B. Riley currently has a “Buy” rating and a $18.00 target price on the stock. B. Riley also issued estimates for FormFactor’s Q3 2019 earnings at $0.27 EPS, Q4 2019 earnings at $0.31 EPS and FY2019 earnings at $1.07 EPS.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on FormFactor (FORM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Medical Stocks For 2019: Pegasystems Inc.(PEGA)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Stock No. 2: Pegasystems (NASDAQ:PEGA), ticker symbol PEGA.Pegasystems is a company that, for a long time, that has been in the AIbusiness. This is an important technology. This is a small-capcompany. It can’t bring the kinds ofGoogle- likeresources to AI. Google is the one that created AlphaGo, the amazing game-playing AI beating the world’s Go champion. That’s not going to come fromPegasystems.

  • [By Logan Wallace]

    Pegasystems (NASDAQ:PEGA) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued on Friday.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Pegasystems (PEGA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Yext (NYSE: YEXT) and Pegasystems (NASDAQ:PEGA) are both business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends.

  • [By Demitrios Kalogeropoulos]

    Pegasystems(NASDAQ:PEGA) announced first-quarter results this week that paired a significant slowdown in sales growth with plummeting earnings. The declines were driven by a shift toward cloud-based revenue that had a more pronounced impact on the books because of the implementation of new accounting rules.

Top 5 Medical Stocks For 2019: Boot Barn Holdings, Inc.(BOOT)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos, Jeremy Bowman, and Steve Symington]

    With that in mind, Motley Fool investors scoured the industry for examples of retailers that boast attractive long-run growth opportunities. Read on to find out why Five Below (NASDAQ:FIVE), lululemon (NASDAQ:LULU), and Boot Barn (NYSE:BOOT) topped that list.

  • [By Lisa Levin] Gainers
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
    Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
    HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
    Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
    Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
    Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
    PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t
  • [By Dan Caplinger]

    That only makes it more important to be selective about the stocks you choose to own. Even under more difficult market conditions, some stocks have continued to push sharply higher. HollyFrontier (NYSE:HFC), Boot Barn Holdings (NYSE:BOOT), and Sarepta Therapeutics (NASDAQ:SRPT) have each tripled since this time last year, and bullish shareholders think that there could be further gains in store for the three companies if some key things keep going right.

Top 5 Medical Stocks For 2019: Whiting Petroleum Corporation(WLL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Whiting Petroleum (WLL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Whiting Petroleum Corp (NYSE:WLL)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $46.75, but opened at $48.93. Whiting Petroleum shares last traded at $50.12, with a volume of 80658 shares trading hands.

  • [By Max Byerly]

    TCW Group Inc. raised its stake in Whiting Petroleum Corp (NYSE:WLL) by 21.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 25,733 shares of the oil and gas exploration company’s stock after purchasing an additional 4,618 shares during the period. TCW Group Inc.’s holdings in Whiting Petroleum were worth $871,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Whiting Petroleum Corp (NYSE:WLL) – Analysts at Jefferies Financial Group increased their Q2 2018 earnings per share (EPS) estimates for Whiting Petroleum in a research note issued on Monday, July 9th. Jefferies Financial Group analyst M. Lear now forecasts that the oil and gas exploration company will earn $0.64 per share for the quarter, up from their prior estimate of $0.63. Jefferies Financial Group also issued estimates for Whiting Petroleum’s Q3 2018 earnings at $0.61 EPS, Q4 2018 earnings at $0.86 EPS, FY2018 earnings at $3.02 EPS, Q1 2019 earnings at $1.24 EPS, Q2 2019 earnings at $0.97 EPS, Q3 2019 earnings at $0.64 EPS, Q4 2019 earnings at $0.72 EPS, FY2019 earnings at $3.57 EPS, Q1 2020 earnings at $0.78 EPS, Q2 2020 earnings at $0.77 EPS and FY2020 earnings at $3.15 EPS.

  • [By Joseph Griffin]

    Whiting Petroleum Co. (NYSE:WLL) – Equities research analysts at Piper Jaffray Companies lifted their Q2 2018 earnings estimates for Whiting Petroleum in a research note issued on Sunday, May 20th. Piper Jaffray Companies analyst K. Harrison now forecasts that the oil and gas exploration company will earn $0.85 per share for the quarter, up from their previous forecast of $0.33. Piper Jaffray Companies currently has a “Hold” rating and a $46.00 target price on the stock. Piper Jaffray Companies also issued estimates for Whiting Petroleum’s Q3 2018 earnings at $0.97 EPS, Q4 2018 earnings at $1.16 EPS, FY2018 earnings at $3.90 EPS, Q1 2019 earnings at $1.70 EPS, Q2 2019 earnings at $1.48 EPS, Q3 2019 earnings at $1.47 EPS, Q4 2019 earnings at $1.59 EPS and FY2019 earnings at $6.24 EPS.

Top 5 Medical Stocks For 2019: Diodes Incorporated(DIOD)

Advisors’ Opinion:

  • [By Shane Hupp]

    JPMorgan Chase & Co. lessened its stake in shares of Diodes Incorporated (NASDAQ:DIOD) by 67.0% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 23,610 shares of the semiconductor company’s stock after selling 47,902 shares during the period. JPMorgan Chase & Co.’s holdings in Diodes were worth $719,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Diodes Incorporated (NASDAQ:DIOD) VP Francis Tang sold 8,600 shares of the company’s stock in a transaction dated Wednesday, May 16th. The stock was sold at an average price of $33.41, for a total value of $287,326.00. Following the completion of the transaction, the vice president now directly owns 86,279 shares of the company’s stock, valued at approximately $2,882,581.39. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

  • [By Money Morning Staff Reports]

    That’s a great way to cash in on the growth of technology without buying into overhyped (and overpriced) semiconductor stocks, like Diodes Inc. (Nasdaq: DIOD), which trades for 111 times earnings.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Diodes (DIOD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Diodes (DIOD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published.